PML/RARA inhibits expression of HSP90 and its target AKT

Maria Liliana Piredda, Girish Gaur, Gianfranco Catalano, Mariadomenica Divona, Cristina Banella, Serena Travaglini, Maria Carmen Puzzangara, Maria Teresa Voso, Francesco Lo-Coco, Nelida Ines Noguera

Research output: Contribution to journalArticle

Abstract

Essential for cell survival, the 90 kD Heat Shock Proteins (HSP90) are molecular chaperons required for conformational stabilization and trafficking of numerous client proteins. Functional HSP90 is required for the stability of AKT, a serine-threonine kinase phosphorylated in response to growth factor stimulation. AKT plays a crucial regulatory role in differentiation, cell cycle, transcription, translation, metabolism and apoptosis. Acute promyelocytic leukaemia (APL) is characterized by the presence of the promyelocytic leukaemia/retinoic acid receptor alpha (PML/RARA) fusion protein, which deregulates expression of several genes involved in differentiation and apoptosis. Here, we report inhibition of HSP90AA1 and HSP90AB1 isomer transcription in blasts isolated from patients with APL, associated with reduction of HSP90 protein expression and loss of control on AKT protein phosphorylation. We show that in vitro treatment of PML/RARA expressing cells with all-trans retinoic acid (ATRA) up-regulates HSP90 expression and stabilizes AKT. Addition of the HSP90-inhibitor 17-(allylamino)-17-demethoxygeldanamycin in combination with ATRA, blocks upregulation of AKT protein, indicating that HSP90 is necessary for ATRA action on AKT. This is the first report proving that expression of HSP90 isomers are directly and differentially repressed by PML/RARA, with critical results on cellular homeostasis of target proteins, such as AKT, in APL blasts.

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Leukemia
Acute Promyelocytic Leukemia
Tretinoin
Proteins
tanespimycin
Up-Regulation
Apoptosis
HSP90 Heat-Shock Proteins
Molecular Chaperones
Protein-Serine-Threonine Kinases
Retinoic Acid Receptor alpha
Cell Survival
Intercellular Signaling Peptides and Proteins
Cell Cycle
Homeostasis
Phosphorylation
Gene Expression
Therapeutics

Keywords

  • Acute promyelocytic leukaemia
  • AKT
  • heat shock protein 90
  • HSP90AA1 and HSP90AB1
  • PML/RARA

ASJC Scopus subject areas

  • Hematology

Cite this

Piredda, M. L., Gaur, G., Catalano, G., Divona, M., Banella, C., Travaglini, S., ... Noguera, N. I. (Accepted/In press). PML/RARA inhibits expression of HSP90 and its target AKT. British Journal of Haematology. https://doi.org/10.1111/bjh.15715

PML/RARA inhibits expression of HSP90 and its target AKT. / Piredda, Maria Liliana; Gaur, Girish; Catalano, Gianfranco; Divona, Mariadomenica; Banella, Cristina; Travaglini, Serena; Puzzangara, Maria Carmen; Voso, Maria Teresa; Lo-Coco, Francesco; Noguera, Nelida Ines.

In: British Journal of Haematology, 01.01.2018.

Research output: Contribution to journalArticle

Piredda, ML, Gaur, G, Catalano, G, Divona, M, Banella, C, Travaglini, S, Puzzangara, MC, Voso, MT, Lo-Coco, F & Noguera, NI 2018, 'PML/RARA inhibits expression of HSP90 and its target AKT', British Journal of Haematology. https://doi.org/10.1111/bjh.15715
Piredda ML, Gaur G, Catalano G, Divona M, Banella C, Travaglini S et al. PML/RARA inhibits expression of HSP90 and its target AKT. British Journal of Haematology. 2018 Jan 1. https://doi.org/10.1111/bjh.15715
Piredda, Maria Liliana ; Gaur, Girish ; Catalano, Gianfranco ; Divona, Mariadomenica ; Banella, Cristina ; Travaglini, Serena ; Puzzangara, Maria Carmen ; Voso, Maria Teresa ; Lo-Coco, Francesco ; Noguera, Nelida Ines. / PML/RARA inhibits expression of HSP90 and its target AKT. In: British Journal of Haematology. 2018.
@article{138ca758211c4ee3b6c5dc144734b749,
title = "PML/RARA inhibits expression of HSP90 and its target AKT",
abstract = "Essential for cell survival, the 90 kD Heat Shock Proteins (HSP90) are molecular chaperons required for conformational stabilization and trafficking of numerous client proteins. Functional HSP90 is required for the stability of AKT, a serine-threonine kinase phosphorylated in response to growth factor stimulation. AKT plays a crucial regulatory role in differentiation, cell cycle, transcription, translation, metabolism and apoptosis. Acute promyelocytic leukaemia (APL) is characterized by the presence of the promyelocytic leukaemia/retinoic acid receptor alpha (PML/RARA) fusion protein, which deregulates expression of several genes involved in differentiation and apoptosis. Here, we report inhibition of HSP90AA1 and HSP90AB1 isomer transcription in blasts isolated from patients with APL, associated with reduction of HSP90 protein expression and loss of control on AKT protein phosphorylation. We show that in vitro treatment of PML/RARA expressing cells with all-trans retinoic acid (ATRA) up-regulates HSP90 expression and stabilizes AKT. Addition of the HSP90-inhibitor 17-(allylamino)-17-demethoxygeldanamycin in combination with ATRA, blocks upregulation of AKT protein, indicating that HSP90 is necessary for ATRA action on AKT. This is the first report proving that expression of HSP90 isomers are directly and differentially repressed by PML/RARA, with critical results on cellular homeostasis of target proteins, such as AKT, in APL blasts.",
keywords = "Acute promyelocytic leukaemia, AKT, heat shock protein 90, HSP90AA1 and HSP90AB1, PML/RARA",
author = "Piredda, {Maria Liliana} and Girish Gaur and Gianfranco Catalano and Mariadomenica Divona and Cristina Banella and Serena Travaglini and Puzzangara, {Maria Carmen} and Voso, {Maria Teresa} and Francesco Lo-Coco and Noguera, {Nelida Ines}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/bjh.15715",
language = "English",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",

}

TY - JOUR

T1 - PML/RARA inhibits expression of HSP90 and its target AKT

AU - Piredda, Maria Liliana

AU - Gaur, Girish

AU - Catalano, Gianfranco

AU - Divona, Mariadomenica

AU - Banella, Cristina

AU - Travaglini, Serena

AU - Puzzangara, Maria Carmen

AU - Voso, Maria Teresa

AU - Lo-Coco, Francesco

AU - Noguera, Nelida Ines

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Essential for cell survival, the 90 kD Heat Shock Proteins (HSP90) are molecular chaperons required for conformational stabilization and trafficking of numerous client proteins. Functional HSP90 is required for the stability of AKT, a serine-threonine kinase phosphorylated in response to growth factor stimulation. AKT plays a crucial regulatory role in differentiation, cell cycle, transcription, translation, metabolism and apoptosis. Acute promyelocytic leukaemia (APL) is characterized by the presence of the promyelocytic leukaemia/retinoic acid receptor alpha (PML/RARA) fusion protein, which deregulates expression of several genes involved in differentiation and apoptosis. Here, we report inhibition of HSP90AA1 and HSP90AB1 isomer transcription in blasts isolated from patients with APL, associated with reduction of HSP90 protein expression and loss of control on AKT protein phosphorylation. We show that in vitro treatment of PML/RARA expressing cells with all-trans retinoic acid (ATRA) up-regulates HSP90 expression and stabilizes AKT. Addition of the HSP90-inhibitor 17-(allylamino)-17-demethoxygeldanamycin in combination with ATRA, blocks upregulation of AKT protein, indicating that HSP90 is necessary for ATRA action on AKT. This is the first report proving that expression of HSP90 isomers are directly and differentially repressed by PML/RARA, with critical results on cellular homeostasis of target proteins, such as AKT, in APL blasts.

AB - Essential for cell survival, the 90 kD Heat Shock Proteins (HSP90) are molecular chaperons required for conformational stabilization and trafficking of numerous client proteins. Functional HSP90 is required for the stability of AKT, a serine-threonine kinase phosphorylated in response to growth factor stimulation. AKT plays a crucial regulatory role in differentiation, cell cycle, transcription, translation, metabolism and apoptosis. Acute promyelocytic leukaemia (APL) is characterized by the presence of the promyelocytic leukaemia/retinoic acid receptor alpha (PML/RARA) fusion protein, which deregulates expression of several genes involved in differentiation and apoptosis. Here, we report inhibition of HSP90AA1 and HSP90AB1 isomer transcription in blasts isolated from patients with APL, associated with reduction of HSP90 protein expression and loss of control on AKT protein phosphorylation. We show that in vitro treatment of PML/RARA expressing cells with all-trans retinoic acid (ATRA) up-regulates HSP90 expression and stabilizes AKT. Addition of the HSP90-inhibitor 17-(allylamino)-17-demethoxygeldanamycin in combination with ATRA, blocks upregulation of AKT protein, indicating that HSP90 is necessary for ATRA action on AKT. This is the first report proving that expression of HSP90 isomers are directly and differentially repressed by PML/RARA, with critical results on cellular homeostasis of target proteins, such as AKT, in APL blasts.

KW - Acute promyelocytic leukaemia

KW - AKT

KW - heat shock protein 90

KW - HSP90AA1 and HSP90AB1

KW - PML/RARA

UR - http://www.scopus.com/inward/record.url?scp=85058085304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058085304&partnerID=8YFLogxK

U2 - 10.1111/bjh.15715

DO - 10.1111/bjh.15715

M3 - Article

AN - SCOPUS:85058085304

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -